1-(4-Acetylbenzenesulfonyl)piperidine-2-carboxylic acid

Catalog No. :
ACUKSC206
CAS No. :
809240-69-5
Molecular Formula :
C14H17NO5S
Molecular Weight :
311.36

IUPAC Name:1-((4-acetylphenyl)sulfonyl)piperidine-2-carboxylic acid

1-(4-Acetylbenzenesulfonyl)piperidine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00Login to see priceInquiryInquiry
100mg95%$101.00Login to see priceInquiryInquiry
250mg95%$132.00Login to see priceInquiryInquiry
1g95%$338.00Login to see priceInquiryInquiry
5g95%$947.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Acetylbenzenesulfonyl)piperidine-2-carboxylic acid
IUPAC Name1-((4-acetylphenyl)sulfonyl)piperidine-2-carboxylic acid
MDL No.MFCD04639672
Molecular FormulaC14H17NO5S
Molecular Weight311.36
SMILESO=C(C1N(S(=O)(C2=CC=C(C(C)=O)C=C2)=O)CCCC1)O
InChI KeyQUWIEIFFNAJQRK-UHFFFAOYSA-N
Synonym2-Piperidinecarboxylic acid, 1-[(4-acetylphenyl)sulfonyl]-;1-(4-Acetylbenzenesulfonyl)piperidine-2-carboxylic acid
CAS No.809240-69-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUKSC206 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDYO148 route compound structure diagram
    ACBDYO1481788-10-9 In Stock
  2. Plus
  3. ACRXGA678 route compound structure diagram
    ACRXGA67815862-86-9 In Stock
  4. Then
  5. ACUKSC206 route product structure diagram
    ACUKSC206809240-69-5
Inquiry

2. ACUKSC206 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUKSC206 route product structure diagram
    ACUKSC206809240-69-5
Inquiry

Comments (0)